BioTransplant and Novartis form xenotransplant company

BTRN, partner Novartis (SWX:NOVN; NVS) and NOVN subsidiary Imutran ( Cambridge, U.K.) will form a new company focused on xenotransplantation. BTRN and NOVN will respectively own 33 and 67 percent of t...